Rarefaction curves of quality reads per sample at (A) phylum and (B) genus level operational taxonomic units (OTUs), in patient and control samples. by Duangnapa Roongpiboonsopit (12829198)

Subjects:

Alpha-diversity analysis at genus level including operational taxonomic unit (OTUs), Chao richness and Shannon diversity indices. by Duangnapa Roongpiboonsopit (12829198)

Subjects:

Clinical characteristics of patients and controls. by Duangnapa Roongpiboonsopit (12829198)

Subjects:

(A) Beta-diversity non-metric multidimensional scaling (NMDS) analysis at genus level, and (B) LEfSe for bacterial species biomarkers representing control vs. stroke groups. by Duangnapa Roongpiboonsopit (12829198)

Subjects:

Microbial metabolic potentials categorized according to KEGG (A) level 1 and (B) level 2, representing control vs. stroke groups. by Duangnapa Roongpiboonsopit (12829198)

Subjects:

Microbiota compositions in percent relative abundance between healthy control and stroke patient individuals (the average microbiota between groups were displayed on the rightmost... by Duangnapa Roongpiboonsopit (12829198)

Subjects:

Manifestations of Post-COVID-19 Conditions (PCC) three months post-acute illness, among those with PCC, by age group^a. by Chelsea S. Lutz (16001569)

Subjects:

Clinical outcomes and COVID-19 treatment during acute illness, by hospitalization status and age group. by Chelsea S. Lutz (16001569)

Subjects:

Log2 fold change (FC), mean and standard deviation (SD) of each lipid specie from the normal liver (NL) and metabolic dysfunction-associated steatohepatitis (MASH) groups, and adju... by Laia Bertran (3685147)

Log2 fold change (FC), mean and standard deviation (SD) of each lipid specie from the normal liver (NL) and simple steatosis (SS) groups, and adjusted p-values. by Laia Bertran (3685147)

Log2 fold change (FC), mean and standard deviation (SD) of each lipid specie from the normal liver (NL) and metabolic dysfunction-associated steatotic liver disease (MASLD) groups,... by Laia Bertran (3685147)

Log2 fold change (FC), mean and standard deviation (SD) of each lipid specie from the simple steatosis (SS) and metabolic dysfunction-associated steatohepatitis (MASH) groups, and... by Laia Bertran (3685147)

Forest plot depicting hazard ratios for the development of cardiovascular diseases. by Teng-Li Lin (5559284)

Subjects:

Forest plot depicting hazard ratios for the development of any cardiovascular diseases stratified by biologic classes, demographics, regions of data source, and comorbidities. by Teng-Li Lin (5559284)

Subjects:

Flow chart of the patient selection. by Teng-Li Lin (5559284)

Subjects:

Demographic characteristics of study subjects after PSM ^* . by Teng-Li Lin (5559284)

Subjects:

Cumulative incidence of any cardiovascular diseases in the BIO-cohort vs. the Non-BIO-cohort. by Teng-Li Lin (5559284)

Subjects:

Frontier analysis based on SDI and age-standardized DALYs rate for thyroid cancer among adolescents and young adults. by Zijian Qiu (17560477)

Table 1_Febuxostat may decrease the incidence of COVID-19 infection among patients with gout: a retrospective cohort study.docx by Weijie Wang (247184)

<b>The loss of insulin-positive cell clusters precedes the decrease of islet frequency and beta cell area in type 1 diabetes</b> by Denise M. Drotar (21679539)

“…Age-corrected data revealed decreased islet frequency and increased inter-islet distances in the type 1 diabetes pancreas. …”